4.7 Article

Longitudinal Study of Cognitive Functioning in Adults with Juvenile Idiopathic Arthritis

Journal

BIOMEDICINES
Volume 10, Issue 7, Pages -

Publisher

MDPI
DOI: 10.3390/biomedicines10071729

Keywords

juvenile idiopathic arthritis; cognitive functions; inflammation; biological therapy

Funding

  1. PAIDI Group of the University of Malaga
  2. Andalusian Network for Clinical and Translational Research in Neurology (Neuro-RECA)

Ask authors/readers for more resources

This study aimed to evaluate cognitive decline in adult patients with juvenile idiopathic arthritis (JIA) and identify associated factors. The results showed that almost one third of the patients experienced cognitive decline after 24 months of follow-up. Average C-reactive protein level, depression, and treatment with biologics were found to be associated with cognitive decline in JIA patients.
Objective: To prospectively evaluate possible decline of cognitive functions in adult patients with juvenile idiopathic arthritis (JIA) and identify associated factors. Patients and methods: We performed a 24-month prospective observational study of adults (>= 16 years) with JIA. The primary outcome measure was decline in cognitive function defined as a worsening of >= 2 points on the scales of the subsets administered to evaluate the different cognitive areas using the Wechsler Adult Intelligence Scale (WAIS) after 24 months: attention/concentration (digit span); verbal function (vocabulary); visual-spatial organization (block design); working memory (letter-number sequencing); and problem solving (similarities). Other variables included average inflammatory activity using C-reactive protein and composite activity indexes, comorbidity, and treatment. Logistic regression was performed to identify factors associated with cognitive decline. Results: The study population comprised 52 patients with JIA. Of these, 15 (28.8%) had cognitive decline at V24. The most affected functions were working memory (17.3%), attention/concentration (9.6%), verbal function (7.7%), visual-spatial organization (7.7%), and problem solving (3.8%). There were no significant differences in the median direct or scale scores for the cognitive functions evaluated between V0 and V24 for the whole sample. The factors associated with cognitive decline in patients with JIA were average C-reactive protein (OR [95% CI], 1.377 [1.060-1.921]; p = 0.039), depression (OR [95% CI], 3.691 [1.294-10.534]; p = 0.015), and treatment with biologics (OR [95% CI], 0.188 [0.039-0.998]; p = 0.046). Conclusion: Cognitive decline was detected in almost one third of adults with JIA after 24 months of follow-up. Systemic inflammatory activity in JIA patients was related to cognitive decline. Patients treated with biologics had a lower risk of decline in cognitive functions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available